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Glutamatergic neuronp–helix transcription factor essential for oligodendrocyte and motoneuron
development in the spinal cord. Olig2-positive (Olig2+) cells in the ventricular zone of the ventral
telencephalon have been shown to differentiate into GABAergic and cholinergic neurons. However, the fate of
Olig2 lineage cells in the postnatal forebrain has not been fully described and Olig2 may regulate the
development of both astrocytes and oligodendrocytes. Here, we examined the fate of embryonic Olig2+
progenitors using a tamoxifen-inducible Cre/loxP system. Using long-term lineage tracing, Olig2+ cells in the
early fetal stage primarily differentiated into GABAergic neurons in the adult telencephalon, while those in
later stages gave rise to macroglial cells, both astrocytes and oligodendrocytes. Olig2+ progenitors in the
diencephalon developed into oligodendrocytes, as observed in the spinal cord, and a fraction developed into
glutamatergic neurons. Olig2 lineage oligodendrocytes tended to form clusters, probably due to local
proliferation at the site of terminal differentiation. In spite of the abundance of Olig2 lineage GABAergic
neurons in the normal neocortex, GABAergic neurons seemed to develop at normal density in the Olig2
deﬁcient mouse. Thus, Olig2 is dispensable for GABAergic neuron speciﬁcation. In contrast, at the late fetal
stage in the Olig2 deﬁcient mouse, astrocyte development was retarded in the dorsal neocortex, but not in
the basal forebrain. Olig2 functions, therefore, in gliogenesis in the dorsal pallium. Short-term lineage tracing
experiments revealed that the majority of late Olig2+ cells were not direct descendants of early Olig2+
progenitors in the fetal forebrain. These observations indicate that embryonic Olig2+ progenitor cells change
their differentiative properties during development, and also that Olig2 plays a role in astrocyte development
in a region-speciﬁc manner.
© 2008 Elsevier Inc. All rights reserved.Introduction
During the development of the central nervous system (CNS),
neuroepithelial cells with neural stem cell characteristics produce a
variety of progenitors for both neurons and macroglial cells. A speciﬁc
progenitor is derived from a speciﬁc domain which is delineated by
the expression of speciﬁc transcription factors (TFs). TFs regulate and
determine cell fates as well as proliferation, migration and axonal
growth. For example, targeted disruption or improper expression of
certain TF changes cell fate (Deneen et al., 2006; Lu et al., 2002;ral Science, Graduate School of
-8556, Japan.
ersity of Connecticut Medical
l rights reserved.Mizuguchi et al., 2001; Sharma et al., 2000; Shirasaki et al., 2006;
Takebayashi et al., 2002). Therefore, some TFs are regarded as cell
type-speciﬁc markers for the embryonic progenitor cells. However,
detailed relationships between embryonic progenitors and their
terminal phenotypes remain largely unknown.
Olig2 is a basic helix–loop–helix transcription factor essential for
oligodendrocytic and motoneuron differentiation in the spinal cord
(Lu et al., 2000, 2002; Takebayashi et al., 2000, 2002; Zhou et al., 2000;
Zhou and Anderson, 2002), and oligodendrocytic speciﬁcation in the
ventral forebrain (Tekki-Kessaris et al., 2001; Parras et al., 2007;
Petryniak et al., 2007). We have been performing lineage analysis of
embryonic cells expressing Olig2 (Olig2+ cells). Olig2+ progenitors in
the early embryonic spinal cord differentiate into motoneurons, and
those in late stages primarily differentiate into oligodendrocytes, with
a lesser number of astrocytes and ependymal cells (Masahira et al.,
2006). In the forebrain, Olig2 expression is initially localized in the
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and lateral ganglionic eminence (MGE and LGE) and zona limitans
intrathalamica (ZLI) (Nery et al., 2002; Takebayashi et al., 2000).
Recently, it was shown that at an early fetal stage of development,
Olig2+ cells in the MGE and LGE differentiate into GABAergic neurons
and cholinergic neurons (Furusho et al., 2006; Miyoshi et al., 2007).
The initially restricted expression of Olig2 in the ventral forebrain also
suggests oligodendrocytic differentiation of Olig2+ progenitor cells
from theMGE (Tekki-Kessaris et al., 2001). Indeed, loss of Olig2 results
inmarked reduction of oligodendrocytic development in the forebrain
(Lu et al., 2002; Takebayashi et al., 2002). By contrast, recent evidence
by others suggests that Olig2 positively regulates gliogenesis, in-
cluding astrocytogenesis in the early postnatal telencephalon (Mar-
shall et al., 2005; Cai et al., 2007). These ﬁndings are contrary to the
view that Olig2 inhibits astrocytic differentiation (Fukuda et al., 2004;
Setoguchi and Kondo, 2004). Therefore, although Olig2+ cells in the
embryonic CNS include oligodendrocyte precursor cells (OPCs) and
subsets of neurons (Masahira et al., 2006; Furusho et al., 2006), further
analysis is necessary to characterize the differentiation of Olig2+ pro-
genitors in the developing forebrain.
In this study, we investigated the fates of embryonic Olig2+ cells in
the forebrain by performing comprehensive lineage tracing experi-
ments using a tamoxifen-inducible Cre/loxP system. Our results de-
monstrate that Olig2+ cells in the early telencephalon primarily
differentiate into GABAergic neurons and later into macroglial cells,
while those in the diencephalon develop into excitatory neurons as
well as oligodendrocytes. Unexpectedly, Olig2+ cells in the late fetal
telencephalon primarily give rise to astrocytes. In addition, Olig2
deﬁciency results in a decreased number of astrocytes in the dorsal
pallium, but not in the basal forebrain area, at a late fetal stage. These
observations indicate that embryonic Olig2+ progenitor cells change
their differentiative properties during development, and also that Olig2
plays a role in astrocyte development in a region-speciﬁc manner.
Materials and methods
Animals
Mice used in this study and the genotyping protocols were described previously
(Novak et al., 2000, Sakai and Miyazaki, 1997, Takebayashi et al., 2002). Olig2KICreER
heterozygous male mice with an ICR background (Japan SLC, Hamamatsu, Japan) were
crossed with female reporter mice. Or, double-heterozygous male mice with
Olig2KICreER and a reporter allele were mated with ICR females. Midday of the plugged
day was termed embryonic day (E) 0.5. We used two reporter mouse lines: Z/EG mice
(Novak et al., 2000), which express GFP upon Cre-mediated recombination, and CAG-
CAT-Z mice (Sakai and Miyazaki, 1997), which express LacZ upon recombination.
Pregnant dams received an intraperitoneal injection of 4-hydroxytamoxifen (4-OHT;
Sigma-Aldrich, St. Louis, MI; 2–3 mg/animal) at E9.5~E17.5 to induce Cre-mediated
recombination in Olig2+ cells, as described previously (Masahira et al., 2006). Double-
heterozygous mice treated with 4-OHT were analyzed at fetal stages, postnatal day 7
(P7) or adult (P30-12 month old). Some pregnant mice received 5-bromo-2′-
deoxyuridine (BrdU; 50 mg/kg body weight; Sigma-Aldrich) 2 h prior to ﬁxation of
fetal (E18.5) mice. To observe the effect of Olig2 deﬁciency, Olig2KICreER heterozygous
micewere crossed to the heterozygous female to obtain Olig2−/−mice. As Olig2 deﬁcient
mice were stillborn, the fetal brain was analyzed at E18.5.
Animals were perfused transcardially with phosphate buffered saline (PBS)
followed by 4% paraformaldehyde in PBS under deep anesthesia with pentobarbital
(100 mg/kg body weight). The brains were removed from the skulls and maintained in
the same ﬁxative overnight at 4 °C, and then immersed in PBS containing 20% sucrose.
Some specimens were ﬁxed with Boudian-II ﬁxative and processed for parafﬁn
preparation (Ono et al., 2004). All animal procedures were conducted in accordance
with guidelines described by the National Institutes of Health Guide for Care and Use of
Laboratory Animals, and approved by the Animal Research Committee of the National
Institute for Physiological Sciences. Fixed brains were cut coronally or sagittally with a
sliding microtome (for parafﬁn sections), a cryostat or a freezing microtome at 7 μm,
18 μm or 50 μm in thickness, respectively. Sections cut with a cryostat were thaw-
mounted onto MAS-coated glass slides (Matsunami Glass Co., Tokyo, Japan), while
those cut with a freezing microtome were collected in PBS.
X-gal staining and immunohistochemistry
Brains from double-heterozygous mice with Olig2KICreER:CAG-CAT-Z were ﬁrst
stained with X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) for histochemistry.Cryostat or free-ﬂoating sections were washed three times for 5 min in PBS and
incubated for 24 hwith X-gal staining solution (16 mMK4[Fe(CN)6], 16 mM K3[Fe(CN)6],
20 mM Tris–HCl (pH7.3), 2 mMMgCl2, and 0.1% X-gal in PBS) at room temperature. The
X-gal staining solution had been treated with 0.001% diethylpyrocarbonate prior to the
incubation to inactivate RNase. Sections were then washed once for 5 min in PBS. The
free-ﬂoating sections were mounted on glass slides and dried in air. They were further
subjected to in situ hybridization (ISH) or immunohistochemistry, or coverslipped after
counterstaining with nuclear fast red or neutral red.
Sections from double-heterozygous mice with Olig2KICreER:Z/EG were stained with
GFP immunohistochemistry to observe detailed morphology of GFP-expressing Olig2
lineage cells. They were ﬁrst pre-treated with 0.05% hydrogen peroxide to inhibit
intrinsic peroxidase activity. Then, they were sequentially incubated with 5% bovine
serum albumin to block non-speciﬁc antibody binding, and with rabbit anti-GFP
antibody overnight (1:3000; Invitrogen/Molecular Probes, Eugene, OR). After washing
with PBS, they were incubated with goat anti-rabbit IgG conjugated to Alexa Fluor 488
(1:2000; Invitrogen/Molecular Probes) or one conjugated to biotin (Vector Lab.,
Burlingame, CA). Sections treated with biotinylated secondary antibody were further
incubated with an avidin–biotin peroxidase complex (ABC elite standard kit; Vector
Lab.) and color was developed by treating them with Tris–HCl buffer (50 mM, pH 7.6)
containing 0.05% 3,3′-diaminobenzidine tetrahydrochloride (DAB) and 0.015% hydro-
gen peroxide.
Recombinant cells were examined to identify their cell type with speciﬁc markers
for neural cells and their subtypes. X-gal-stained sections were treated with primary
antibody (see below), followed by the ABC method (see above). Sections from double-
heterozygous mice (Olig2KICreER:Z/EG) were double-labeled by an immunoﬂuorescent
method. A mixture of primary antibodies was applied to the sections for one to two
overnights. After washing the sections with PBS, they were incubated for 1 h with a
mixed solution of species-speciﬁc secondary antibodies that were conjugated to Alexa
Fluor 350, 488, 594 or 633. Nuclei of cells were counterstained with Hoechst33342
(0.1 μg/mL, 10–30 min). The following primary antibodies were used: rat anti-GFP
(1:2000, Nacalai Tesque, Kyoto, Japan), rat anti-platelet-derived growth factor receptor
α (PDGFRα;1:500, BD Bioscience, San Diego, CA), rabbit anti-GABA for inhibitory
neurons (1:2000, Sigma-Aldrich), rabbit anti-GSTpi for mature oligodendrocytes
(1:1000, MBL, Nagoya, Japan; Tansey and Cammer, 1991), rabbit anti-GFAP for
astrocytes (1:2000, Dako, Denmark), rabbit anti-GLAST for astrocyte progenitors
(1:5000, a gift from Dr. Masahiko Watanabe, Hokkaido University; Shibata et al., 1997),
mouse anti-NeuN for mature neurons (1:1000, Chemicon, Temecula, CA), mouse anti-
class III β-tubulin for immature neurons (1:4000, Tuj1; Covance, Berkley, CA), rabbit
anti-NG2 for OPCs or synantocytes (1:1000, Chemicon; Butt et al., 2005a), mouse anti-
phosphate activated glutaminase (PAG) for excitatory neurons (a gift from Dr. Takeshi
Kaneko, Kyoto University; ﬁnal conc. 2 μg/mL; Kaneko et al., 1995), mouse anti-CAM
kinase II for excitatory neurons (1:500, Chemicon), mouse anti-BrdU (1:5000, BD
Bioscience), rat anti-BrdU (1:200, Abcam, Cambridge, UK), rabbit anti-Iba1 for microglia
(1:1000, Wako, Osaka, Japan) mouse anti-ZO1 for adherens junction in the VZ cells
(1:20, a gift from Dr. Shoichiro Tsukita, Kyoto University; Yonemura et al., 1995), rabbit
anti-Olig2 (1:200, IBL, Takasaki, Japan), rabbit or goat anti-Olig2 (1:1000, Chemicon)
and rabbit anti-nestin for radial glia (1:500, IBL).
In situ hybridization
The method for ISH on cryostat sections was modiﬁed slightly from a previously
described method (Ding et al., 2005). The following cDNAs were used as probes: GAD67
(GAD1; Genbank accession number, NM_008077, nt_281–821, a gift from Dr. Yanagawa,
Gunma University) and GAD65 (GAD2; NM_008078, nt_602–1414, a gift from Dr.
Yanagawa, Gunma University) were used as markers for GABAergic interneurons.
Vesicular glutamate transporter 1 (VGluT1; NM_182993, nt_618–1266) and VGluT2
(NM_080853, nt_735–1324) were used as markers for excitatory neurons. Sonic
hedgehog (Shh; NM_009170, nt_69–1980, a gift from Dr. Andy McMahon, Harvard
University, and Dr. Sumihare Noji, Tokushima University) was used for identiﬁcation of
the ZLI. Fibroblast growth factor receptor 3 (FGFR3; NM_008010, nt_205–2763) and
GLAST (Ma et al., 2006; Ogawa et al., 2005; a gift from Dr. Koichi Tanaka, Tokyo Med.
Dent. University) were used to identify astrocytes or their precursor cells. Colony
stimulating factor1 receptor (c-fms; Ma et al., 2006) was utilized as a microglial marker
and PLP (Kagawa et al., 1994) was used for oligodendrocyte. VGluT1, VGluT2, and FGFR3
cDNAs were cloned by reverse transcription polymerase chain reaction. After ISH, some
brains from Z/EG mice were further subjected to GFP immunohistochemistry with an
ABC method. To obtain maximal sensitivity for GABAergic neurons, probes for GAD65
and GAD67 were sometimes used as a mixed probe solution.
Quantitative analysis
The total number of recombinant cells in the adult brain was estimated by
counting GFP+ cells in every fourth section at 50 μm in thickness and multiplying
by four. The fetal forebrain analyzed here encompassed the telencephalon and the
diencephalon. The telencephalon included the cerebral cortex, olfactory bulb and
basal forebrain rostral to the optic chiasm. The diencephalon included the dorsal
thalamus, ventral thalamus and hypothalamus between the optic chiasm and caudal
limit of the mammillary body. At least three mice were used for estimation of the
total number of recombinant GFP+ cells. The percentage of certain cell types among
the recombinant cells was determined by enumerating the number of double-
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forebrain.
To analyze the effects of Olig2 deﬁciency, the density of inhibitory neurons and
astrocyte progenitors was examined by counting GAD mRNA+ cells in the cerebral
cortex and GLAST or FGFR3mRNA+ cells in the telencephalon, respectively, in unit areas
(290 μm×220 μm, or 580 μm×440 μm) of randomly chosen areas. Results were
compared between Olig2 deﬁcient and wild/heterozygous mice and analyzed with the
Student's t-test. At least three animals were used in each group and at least ﬁve sections
were examined in each animal.
Figure arrangement
Bright-ﬁeld and epiﬂuorescent photomicrographs were takenwith a digital camera
(DP70 andDP71, Olympus, Tokyo, Japan). All digital images, including those takenwith a
con-focal laser scanning microscope (LSM-510, Carl Zeiss, Germany; FV1000, Olympus,
Japan) were imported into Photoshop CS (Adobe Systems) for construction of ﬁgures.
Results
Gradual dispersal of Olig2+ cells in the developing forebrain
We previously demonstrated expression of Olig2-mRNA in the E9.5
and E12.5 forebrain (Furusho et al., 2006). To better understand the
distribution of Olig2+ cells that underwent recombination, the spatio-
temporal expression pattern of Olig2 proteinwas immunohistochemi-
cally determined with high precision in the fetal forebrain (tele-
ncephalon and diencephalon). In the E9.5 telencephalon, Olig2
expression was reminiscent in the ventral part (Fig. 1A, arrowhead).Fig. 1. Immunohistochemical localization of Olig2+ cells in the developing forebrain. Coronal
Olig2 expression in the telencephalonwas reminiscent in the ventral part (arrowhead in pan
(B, F) [E12.5], Olig2+ cells were observed in the VZ of the ventromedial telencephalon includin
to the zona limitans intrathalamica (ZLI, arrowhead). (C, G) [E14.5], Olig2+ cells were distribut
of the hypothalamus (G, Hypth). Note that the mantle layer of the ventral telencephalon and d
(dth) did not. (D, H) [E17.5], Olig2+ cells were widely distributed throughout the forebrain. N
panels D, H) which are magniﬁed in Supplement Figs. 1C, D. (I–K), Sagittal sections showing
order (K). Olig2+ cells were observed ventrally to the ZLI which itself did not expresses Olig2 (
in the caudal hypothalamus (K, arrow). Hipp, hippocampus. LGE, lateral ganglionic eminencOlig2+ cells appeared in the ventral telencephalon by E10.5 (not
shown), and, until E12.5, they were mostly localized in the VZ of the
MGE, septum and anterior entopeduncular areawith a faint labeling in
the LGE (Fig. 1B). No or few labeled cells were found in the mantle
layer or dorsal pallium. By E14.5, Olig2 immunoreactivity in the LGE
gradually intensiﬁed and Olig2+ cells were distributed throughout the
VZ of the ventral telencephalon (Fig. 1C). In addition, labeled cells
were scattered in the mantle layer of the ventral telencephalon.
However, a very limited number of Olig2+ cells were detected in the
dorsal neocortex at this stage (Figs. 1C, G). By E17.5, Olig2+ cells were
widely distributed throughout the telencephalon including the
neocortex (Figs. 1D, H). The VZ of the striatum still contained
densely-packed Olig2+ cells. It is worth noting that, at this stage, the
dorsal VZ and/or subventricular zone (VZ/SVZ) of the hippocampus
and that underneath the corpus callosum contained Olig2+ cells (Figs.
1D, H, arrowhead; Supplement Fig. 1). These Olig2+ cells in the VZ/SVZ
incorporated BrdU during 2 h pulses, expressed nestin and were
directly facing the ventricle with the expression of ZO-1, an adherens
junction protein, all of which are characteristics of radial glia or VZ
cells (Supplement Figs.1E–M). Thus, in a later fetal stage, the dorsal VZ
of the telencephalon also seemed to generate Olig2+ lineage cells.
In the diencephalon, Olig2+ cells appeared from E9.5. They were
detected in the restricted region of the diencephalon, and formed
bilateral spots in the neuroepithelial layer of the ventral diencephalon
(Fig. 1E, arrowhead) and a few in the dorsal portion. By E12.5, Olig2+and sagittal sections of fetal forebrain showing distribution of Olig2+ cells. (A, E) [E9.5],
el A) while that in the diencephalon was found in bilateral spots (arrowhead in panel E).
g medial ganglionic eminence (B, MGE), and in the prethalamus (F, Preth) that is ventral
ed in the VZ of the striatum (Str) and septum (Spt) in the telencephalon (C) and in the VZ
iencephalon contained labeled cells while the dorsal neocortex and the dorsal thalamus
ote that the VZ/SVZ of the dorsal telencephalon contained Olig2+ cells (arrowheads in
Olig2 and Shh expression in the E12.5 diencephalon, arranged in a medial (I) to lateral
I, asterisks) but did express morphogen Shh (J, arrows). Olig2+ cells were also distributed
e. NCx, neocortex. Scale bars in panels A, E=100 μm, in panels B–D and F–H, K, 500 μm.
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the ZLI, which secretes the morphogen Shh, while Olig2+ cells were
not observed in the ZLI itself (Figs. 1F, I, J). Cells ventral (or rostral) to
the ZLI showed stronger immunoreactivity to Olig2 than those dorsal
(caudal) to the ZLI, the former corresponding to the prethalamus
derived from prosomere 3 (p3; future ventral thalamus; Puelles and
Rubenstein, 2003) (Figs. 1F, I). In addition, the most caudal region ofFig. 2.Neuronal andmacroglial differentiation of embryonicOlig2+ cells in the adult forebrain
heterozygousmice stainedwith GFP immunohistochemistry. Animals were treatedwith 4-OH
(C) Oligodendrocyte-like cell. (D–F) A neuron-like GFP+ cell (D) expressed NeuN (arrow in pan
nuclei. (G–I) An astrocyte-like bushy cell (G) was immunoreactive for GFAP (arrow in panel H)
express GFAP (K), indicative of ﬁbrous astrocyte. (M–O) Oligodendrocyte-like cells (M) expre
Oligodendrocyte-like GFP+ cells formed a loosely-arranged cluster in the basal forebrain. (Q–S
(T–W) Projection pictures arranged from optical sections taken by a CLSM. Oligodendrocyte
irregular contours did not. (V, W) GFP+ cells expressed NG2 proteoglycan. Scale bars in panethe ventral diencephalon contained numerous Olig2+ cells (Fig. 1K,
arrow) as observed at E14.5 (Fig. 1G). In the diencephalon at E14.5,
Olig2+ cells were found in the prethalamus and hypothalamus,
especially in the VZ (Fig. 1G). Far fewer labeled cells were observed
in the dorsal thalamus. By E17.5, Olig2+ cells were widely distributed
throughout the diencephalon, including the dorsal thalamus mantle
layer. The neuroepithelial cells facing the third ventricle showed. Detailedmorphologyof recombinant cells in the adult brain of Olig2KICreER:Z/EG double-
Tat fetal stages (seeMaterials andmethods). (A) Neuron-like cell. (B) Astrocyte-like cell.
el E). Blue color in panel F (as well as in panels I, L, O, P, S) is Hoechst33342 staining of cell
indicative of protoplasmic astrocyte. (J-L) GFP+ thick processes (arrow) in the optic tract
ssed Olig2 (N) in the adult brain. Double-positive cells are indicated by arrowheads. (P)
) Three oligodendrocyte-like cells (arrows in panel Q) in the cluster expressed GSTpi (R).
-like GFP+ cells with round perikarya (U, arrows) expressed GSTpi (T) while those with
ls C, I, and W=20 μm, in panels F, L, O, S, and U=50 μm, and in panel P=500 μm.
Fig. 3. Distribution of Olig2 lineage recombinant cells in the adult forebrain following
treatment with tamoxifen at fetal stages. Recombinant GFP+ cells were plotted on
montage pictures of adult forebrain coronal sections. Each dot indicates a recombinant
cell. Time of 4-OHT (TM) treatment is indicated at the left side of the pictures. Note that
neuronal cells (yellow spots) are uniformly distributed in the forebrain, while glial cells,
especially oligodendrocytes (red spots), tended to form clusters in E12.5TM and
E14.5TM animals (C–F). An arrow in panel D indicates one such cluster in the ﬁmbria.
Scale bar=1 mm.
Fig. 4. Proportion of neuronal and macroglial cells derived from Olig2+ cells.
Percentages of neuronal and glial cell types among recombinant cells after 4-OHT
treatment at fetal stages are shown in each graph (means±S.E.M). N, neuron-like cells
(black). As, astrocyte-like cells (red). OL, oligodendrocyte-like cells (green). In the
telencephalon, 4-OHT treatment at E12.5 resulted in appearance of more neuron-like
cells (B) while that in later fetal stages resulted in more astrocyte-like cells (D, F). In the
diencephalon, macroglial cells, especially oligodendrocyte-like cells, appeared most
abundantly from Olig2+ cells (C, E, G), except at very early stages (A). Neurogenesis in
Olig2+ cells lasted even after E16.5 in the telencephalon (F) while that had ceased
completely by E16.5 in the diencephalon (G). (H, I) Sequential changes of proportions of
neuronal or macroglial cell generation from Olgi2+ cells in the telencephalon (H) and
the diencephalon (I).
460 K. Ono et al. / Developmental Biology 320 (2008) 456–468intense Olig2 immunoreactivity (Fig. 1H). The results showed an
initially restricted localization and then a subsequent dispersal
of Olig2+ cells in the forebrain, both in the telencephalon and
diencephalon.
Embryonic Olig2+ cells persist in the adult brain as neurons and
macroglial cells
We next performed long-term lineage tracing of embryonic Olig2+
cells (Figs. 2–4; Supplement Figs. 2 and 3). Olig2+ cells in the fetalforebrain were labeled with GFP or LacZ by Cre-mediated recombina-
tion after the 4-OHT injection, and these brains were then analyzed at
adult stages. Some of the recombinant cells failed to express cell type-
speciﬁc markers (see below). Therefore, we categorized the recombi-
nant Olig2 lineage cells based on a standardmorphologic classiﬁcation
(Hosokawa and Mannen, 1963; Leibnitz et al., 1982; LeVine and
Goldman, 1988), in the adult Olig2KICreER:Z/EG forebrain. The mor-
phological categorizations of neurons, astrocytes, or oligodendrocytes
were as follows. Neuron-like cells had a relatively large, round or oval
cell body with smooth contours, and extended multiple longer
processes. Their thicker processes tapered towards their tips and
sometimes bore varicose protrusions which are apparently dendrites
and spines (Fig. 2A). Astrocyte-like cells show a bushy proﬁle in the
gray matter (Figs. 2B, G) and extend thick processes in the white
matter (Fig. 2J). Oligodendrocyte-like cells have a smaller cell body
(usually less than 10 μm) with round or irregular contour. They extend
461K. Ono et al. / Developmental Biology 320 (2008) 456–468multiple processes thatweremuch thinner and shorter than processes
of neuron-like cells (Fig. 2C) and they never had protrusions. A few
recombinant cells were occasionally detected in the ependymal layer
(not shown), and they were excluded from enumeration because their
appearance was sporadic and they were rare compared with other
kinds of cells. In this way, nearly all of the recombinant GFP+ cells
observed at the adult stage could be categorized into three cell types.
We did not observe recombinant cells with a typical microglial
morphology.
To conﬁrm the validity of the morphological classiﬁcation, we next
examined the expression of cell type-speciﬁc markers. Neuron-like
cells were frequently immunoreactive to NeuN (Figs. 2D–F; 78.6
±9.04% of the neuron-like cell population; mean±S.E.M.) and
expressed enzymes for neurotransmitter synthesis (see below).
Astrocyte-like bushy cells were immunoreactive to GFAP in the gray
matter, corresponding to protoplasmic astrocytes (Figs. 2G–I). In
addition, GFAP+, thick processes in the white matter (mostly in the
optic tract) were apparently from ﬁbrous astrocytes (Figs. 2J–L).
Approximately 40% of astrocyte-like cells expressed GFAP, which
is consistent with a previous report that showed that only some
astrocytes express GFAP (Tanaka et al., 2007). Oligodendrocyte-like
cells expressed Olig2 (Figs. 2M–O; 53.4±7.51% of the oligodendrocyte-
like cell population), GSTpi (Figs. 2Q–U; 28.1±11.9%), or NG2 (Figs. 2V,
W; 25.7±9.51%). Therefore, oligodendrocyte-like cells categorized by a
proﬁle included OPCs or NG2+ cells/synantocytes/polydendrocytes
(Butt et al., 2005a; Nishiyama et al., 2002; Nishiyama et al., 2005; Zhu
et al., 2007). GSTpi+ cells usually had a round perikaryon and ex-
tended myelin-like processes (Figs. 2T, U) whereas NG2+ cells tended
to have a perikaryonwith an irregular contour (Figs. 2V, W). Although
not all of the oligodendrocyte-like cells expressed GSTpi or NG2, they
never expressed GFAP. Similarly, astrocyte-like cells were not im-
munopositive for either GSTpi or NG2. Olig2 was not expressed in
astrocyte-like cells of the adult brain, except in the olfactory bulb.
While less than 5% of astrocyte-like GFP+ cells expressed Olig2 in
the forebrain (3.58±4.59% in the telencephalon, 3.62±2.48% in the
diencephalon), approximately one fourth of the astrocyte-like cells
exhibited nuclear Olig2 expression in the olfactory bulb of 5 week old
animals (27.4±8.49%). In addition, neuron-like cells did not express
markers for glial cells. These observations conﬁrmed the accuracy of
the morphological classiﬁcation which was applied for the categor-
ization of recombinant cell types in this study. No or few GFP+ cells
expressed Iba1 or c-fms mRNA, markers for microglia (not shown).
Thus, the results show that embryonic Olig2+ cells persist in the adult
forebrain and give rise to neurons and macroglial cells.
Differentiative properties of embryonic Olig2+ cells are spatio-temporally
different in the forebrain
We next examined the spatio-temporal distribution of Olig2
lineage cells and their differentiation in the adult forebrain (Fig. 3).
Each dot in Fig. 3 indicates a recombinant cell, classiﬁed by mor-
phology. The total number of recombinant cells in the adult forebrain
gradually increased as the time of 4-OHT treatment was delayed to
later developmental times (Supplement Fig. 2). When 4-OHT was
injected at E9.5, no or few recombinant cells appeared in the
telencephalic region (4.25±1.65 cells/telencephalon, n=4 brains).
Recombinant GFP+ cells sporadically appeared in the cerebral cortex
and basal forebrain (Fig. 3A). As expected from the Olig2+ cell
distribution (Figs. 1B, F), 4-OHT treatment at E12.5 induced the ap-
pearance of more recombinant cells in the telencephalon (Figs. 3C, D;
4363±278 cells/telencephalon, n=3 brains). Neuron-like cells were
the most abundant type of recombinant cells, as approximately 70%
of recombinant cells showed a neuron-like proﬁle (Fig. 4B). They
were widely distributed throughout the telencephalon, including
the olfactory bulb, neocortex, striatum, amygdala, hippocampus and
other telencephalic areas (Figs. 3C, D). Nearly all of the recombinantcells in the olfactory bulb were neuron-like cells (94.1±1.25% of
recombinant cells; n=4 brains; Supplement Fig. 3A). Macroglia-like
cells also appeared in the telencephalon of the same brain.
Interestingly, most of the macroglial cells, especially oligodendro-
cyte-like cells, tended to form loosely-arranged clusters (Figs. 2M—P,
T,U and 3D). Such clusters of oligodendrocyte-like cells contained
several to over a hundred GFP+ cells (Fig. 2P) while astrocyte-like
clusters contained only several cells. These results indicate that OPCs
proliferate massively where myelination occurs, which is consistent
with previous results showing proliferating OPCs in the CNS
parenchyma (Ono et al., 2001) and terminal mitosis of myelinating
oligodendrocytes in the white matter (Skoff et al., 1976). Although
most non-neuronal recombinant cells were mainly distributed in the
ventral forebrain, the dorsal telencephalon, including the hippocam-
pus and ﬁmbria, contained oligodendrocyte-like cell clusters (Fig. 3D,
arrow). Only a few astrocyte-like GFP+ cells appeared in the adult
neocortex (not shown). When 4-OHT was administered at E14.5, the
recombinant cell distribution (Figs. 3E, F) was generally similar to
that observed following administration at E12.5. The estimated
number of recombinant cells in the telencephalon was 3,158±506
(n=5 brains). The proportion of neuron-like cells decreased to 30%
(Figs. 4D, H). By contrast, the proportion of macroglia-like cells in-
creased in the adult telencephalon (Figs. 4D–I). Oligodendrocyte-like
cells also tended to form loose clusters, as observed in the forebrain
following administration of 4-OHT at E12.5 (Figs. 3E, F). When 4-OHT
was injected at E16.5 or E17.5, the number of recombinant GFP+ cells
greatly increased in the adult telencephalon (Figs. 3G, H; 15,571
±5672 cells/telencephalon; n=3 brains). For the most part, Olig2+
cells differentiated into macroglial cells (Figs. 3G, H and 4H).
Unexpectedly, astrocyte-like bushy cells, but not oligodendrocyte-
like cells, tended to be the most abundant cell type among the
recombinant cell population in the telencephalon (Figs. 4F, H). They
were widely distributed throughout the telencephalic regions in both
white and gray matter (Figs. 3G, H), although the white matter in
telencephalon contained no or few astrocyte-like cells. However,
these cells did not tend to show large cluster formation, probably
because Olig2+ cells were distributed widely and had started active
proliferation by this stage. Neuron-like cells accounted for less than
5% of the recombinant cell population, and most of them were
observed in the olfactory bulb. Approximately half of the recombi-
nant cells revealed a neuron-like proﬁle in the adult olfactory bulb
following E16.5 or E17.5 4-OHT treatment (51.5±4.65%, n=5 brains;
Supplement Figs. 3B–D).
With regard to the diencephalon, treatment with 4-OHT at E9.5
revealed a moderate number of GFP+ cells (519±232 cells/diencepha-
lon). They were mostly observed in the caudal diencephalon such as
the ventral thalamus and hypothalamus (Figs. 3A, B), and were a
mixed population of neuronal and macroglial cells (Figs. 4A, I). 4-OHT
treatment at E12.5 resulted in more than 1000 recombinant cells in
the diencephalon (1274±305). Oligodendrocyte-like cells were the
most abundant recombinant cell type induced by the E12.5 or later 4-
OHT treatment, while the next most abundant were astrocyte-like
cells (Figs. 4C, E, I). They were distributed in the ventral thalamus and
hypothalamus, while a very few cells were found in the dorsal
thalamus. The distribution of neuron-like cells was similar to that of
macroglial cells, though the proportion of neuron-like cells decreased.
In animals treated with 4-OHT at E14.5 or later, the recombinant cell
number in the diencephalon further increased, and both types of
macroglial cells were observed throughout the diencephalon. No or
few recombinant cells in the diencephalon showed neuron-like
morphology when 4-OHT was administered at E16.5 or later
(Figs. 4G, I).
The relationship between the embryonic age at which recombina-
tion was initiated and the ﬁnal morphological phenotypes of Olig2+
cells is summarized in Figs. 4H, I. This suggests that forebrain Olig2+
cells change their differentiative properties during early development.
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gliogenesis increased. Olig2+ cells during late fetal stages generated
glial cells, including abundant astrocytes in the telencephalon, while
those in the diencephalon tended to give rise to oligodendrocytes.
Therefore, the differentiative properties of Olig2+ cells seem to
depend upon the developmental stage and the speciﬁc anatomical
region.
Cessation of Olig2 expression in the Olig2 lineage cells
Long-term lineage tracing experiments demonstrated that the
differentiative properties of early Olig2+ progenitor cells are appar-
ently different from those of late Olig2+ progenitors. If Olig2+
progenitor cells in later fetal stage are direct descendants of those in
the early fetal stage, recombinant cell population induced by E12.5 4-
OHT treatment (Figs. 3C, D) should include more glial cells (Figs. 3G,
H), as reporter expression was continuous after recombination. We
next performed short-term lineage analysis to examine continuous
Olig2 expression in the Olig2 lineage cells.
When Olig2+ cells were marked with LacZ in Olig2KICreER:CAT-Z
mice by 4-OHT injection at E9.5 and the labeled cells were analyzed
at E14.5, LacZ+ cells were mainly distributed in the parenchyma of
the diencephalon. However, less than 1% of X-gal+ cells were
immunopositive for Olig2 (Figs. 5A, B; 0.60±0.25 %, n=4 brains).
When Olig2+ cells at later stages such as E13.5 or E14.5 were labeled
with GFP in Olig2KICreER:Z/EG mice by the 4-OHT treatment and
analyzed 3 days later, recombinant GFP+ cells were widely observed
in the basal forebrain, and fewer in the dorsal pallium. Approxi-
mately one third of GFP+ recombinant cells continued nuclear Olig2
expression 3 days after the recombination (Fig. 5C; 36.8±4.70%; n=3
brains). While a very limited number of GFP+/Olig2+ cells were seen
in the intermediate zone of the cortex and hippocampus (Fig. 5D),
none of the GFP+ cells was Olig2+ in the VZ/SVZ of the dorsal
pallium (Fig. 5E). These results indicate that Olig2 expression is not
always continuous and that more than half of the Olig2 lineage cells
cease Olig2 expression within a few days after the initiation of
recombination. Therefore, although Olig2+ cells gradually spread
from the ventral to dorsal regions of the forebrain (Fig. 1), not all of
the Olig2+ cells in late fetal stages were descendants of Olig2+ cells
at early stages.
In order to understand cell types of GFP+/Olig2+ and GFP+/Olig2−
cells in the short-term lineage analysis, we examined expression of
cell type markers in the over 2000 GFP+ cells in the late fetal stage.
When fetuses were treated with 4-OHT at E13.5 and analyzed at
E16.5, one third of GFP+ cells expressed Olig2. Most of the GFP+/
Olig2+ cells in the forebrain expressed either PDGFRα (42.9 % of
GFP+/Olig2+ cell population) or GLAST (58.8 %), markers for
oligodendrocyte and astrocyte precursors, respectively (Figs. 5G,
H), whereas class III β tubulin, a marker for immature neurons, was
expressed by a small number of GFP+/Olig2+ cells (9.42 %; not
shown). The above value suggests the presence of cells co-
expressing both progenitor markers, which is supported by the
observation that approximately 15 % of GLAST+ cells co-expressed
PDGFRα and vice versa in the late fetal stage (not shown). More
than half of the GFP+/Olig2− cells failed to express any cell type-
speciﬁc markers, while approximately one-ﬁfth of GFP+/Olig2− cells
were immunopositive for class III β tubulin (Fig. 5F) and a lesser
number expressed GLAST (not shown). Therefore, Olig2 lineage cells
that ceased Olig2 expression included neuronal cells while those
retaining Olig2 expression were mostly a glial precursor population,
both astroglial and oligodendroglial.
GABAergic and glutamatergic neuron differentiation from Olig2+ cells
Olig2+ progenitor cells in the early GE are known to differentiate
into GABAergic (Miyoshi et al., 2007) and cholinergic neurons(Furusho et al., 2006). However, it is not clear whether Olig2+ cells
differentiate into other neuronal subsets such as excitatory neurons in
the telencephalon and in the diencephalon. We next examined
neuronal subtypes in the forebrain.
In the adult Olig2KICreER:Z/EG cerebral cortex after E12.5 4-OHT
treatment, approximately 60% of the neuron-like GFP+ cells were
immunoreactive for GABA (60.8±5.91%, n=5 brains; Figs. 6A–C),
and more than three-quarters of neuron-like cells expressed GAD
mRNA (Fig. 6D). Thus, the majority of neuronal Olig2 lineage cells
were GABAergic neurons in the dorsal cortex including the hip-
pocampus (Figs. 6E–G). In the diencephalon, recombinant GFP+
cells induced E12.5 or earlier were distributed in the thalamic
reticular nucleus or other prethalamus areas, showing overlapping
distribution with GAD+ cells (Figs. 6E, H, I, J). In addition, approx-
imately 35% of total recombinant cells expressed GAD67 mRNA
in the basal forebrain of Olig2KICreER:CAT-Z postnatal mice (37.4±
12.7%, n=7 brains; Supplement Fig. 4). Thus, GABAergic neurons
may be the most abundant neuron subtype derived from the
early embryonic Olig2+ cells in GE and in the area surrounding the ZLI.
VGluT1 and VGluT2 are expressed in glutamatergic excitatory
neurons in the telencephalic region and diencephalic and lower
brainstem regions, respectively (Kaneko and Fujiyama, 2002). Pyr-
amidal neurons in the cerebral cortex and the hippocampus, as well as
dentate granule cells, expressed VGluT1 mRNA intensely. However, a
very limited number of neurons co-expressed VGluT1 and reporter
molecules in the cortex. Approximately 2% of X-gal+ recombinant cells
expressed VGluT1 mRNA in the dorsal or ventral pallium of the
Olig2KICreER:CAT-Z double-heterozygous P7 following E12.5 4-OHT
treatment (Figs. 6K–N, arrows). In addition, no or few recombinant
neurons showed a pyramidal neuron proﬁle or only a few GFP+ cells
expressed othermarkers for excitatory neurons such as PAG or CAMKII
(not shown) (Kaneko et al., 1995; Terashima et al., 1995). In contrast, a
considerable number of reporter cells expressed VGluT2 mRNA in the
caudal hypothalamus at perinatal and postnatal stages: 31.2±6.85% of
the total recombinant cells observed in the E17.5 hypothalamus
expressed VGluT2 mRNA following E9.5 and E10.5 4-OHT treatment
(n=3 brains; Figs. 7A–C). In addition, the adult caudal hypothalamus
contained a small number of X-gal+ Olig2 lineage cells expressing
VGluT2 mRNA (Fig. 7D). Therefore, Olig2 lineage neuronal cells
differentiate into excitatory neurons in the ventral diencephalon,
which persist in the adult hypothalamus. Since Olig2 is expressed in
the ventral diencephalon at fetal stage, Olig2 lineage glutamatergic
neurons seem to be derived from the ventral diencephalon (caudal
hypothalamus; arrow in Fig. 1K).
Effects of Olig2 deﬁciency on the development of GABAergic neurons and
astrocytes
The results above demonstrated that GABAergic neurons differ-
entiated from early Olig2+ progenitors and astrocytes differentiated
from late Olig2+ progenitors in the forebrain. These results raise
another question: Is Olig2 essential for GABAergic or astrocytic
speciﬁcation in these areas? We next analyzed Olig2 lineage
differentiation in Olig2 deﬁcient mice. As Olig2 deﬁcient mice are
stillborn, Olig2−/− fetuses were examined at E18.5. In the Olig2−/− brain
at E18.5, the overall pattern of GAD mRNA expression seemed to be
identical to that of the wild type/heterozygous brain (Figs. 8A, B). The
dorsal cerebral cortex at E18.5 contained a similar number of GAD67
mRNA expressing cells per unit area (Figs. 8C, D; KO, 207±38.2, and
wild/heterozygous, 215±23.9, per unit area 580 μm×440 μm, n=3
brains each). Therefore, Olig2+ cells give rise to GABAergic neurons
normally in the absence of Olig2.
We also examined astrocyte development in late (E18.5) fetal
stages. FGFR3, GFAP and GLAST were used as markers for astrocytes
or astrocytic progenitors. First, we examined expression of GFAP and
GLAST with an immunohistochemical method. Expression patterns
Fig. 5. Cessation of Olig2 expression in the Olig2 lineage cells. (A, B) Coronal section through the diencephalon of E14.5 Olig2KICreER:CAT-Z double-heterozygous mouse treated with
4-OHT at E9.5. The section was stained with X-gal histochemistry followed by Olig2 immunohistochemistry. The area marked by an arrow is magniﬁed in panel B. (B) A higher
magniﬁcation picture of the prethalamus in panel A. The recombinant Olig2 lineage cells were labeled with X-gal histochemistry (blue; arrowheads), and Olig2+ cells weremarked by
a black reaction product, developed with a DAB/0.1% nickel chloride /H2O2 solution. Note that none of the Olig2 lineage X-gal+ cells co-expressed Olig2 protein. Sections were
counterstained with nuclear fast red. (C–E) The E17.5 basal forebrain (C) and hippocampus (D, E) of the Olig2KICreER:Z/EG mouse were treated with 4-OHT at E14.5. The sections were
double-labeled with GFP (green) and Olig2 (red) immunohistochemistry. Blue color is nuclear staining with Hoechst33342. (C) A GFP+ cell (arrowhead) continued to express Olig2
while the remaining four cells (arrows) were not positive for Olig2. (D, E) GFP+ Olig2 lineage cells appeared in the hippocampus 3 days after recombination. A GFP+ cell in the
intermediate zone (IZ) retained Olig2 expression (arrowhead in panel D) whereas GFP+ cells in the VZ/SVZ were not labeled with Olig2 (arrow in panel E). GFP+ recombinant cells are
magniﬁed in insets. CP, cortical plate. DG, dentate gyrus. (F–H) Expression of cell type-speciﬁc markers in Olig2 lineage GFP+ cells with or without Olig2 expression. Arrowheads
indicate GFP+ cells. Animals were treated with 4-OHTat E13.5 and analyzed after 3 days.While Olig2 lineage GFP+ cells that were negative for Olig2 immunoreactivity expressed class
III β tubulin (Tuj1, Fc), those with Olig2 immunoreactivity expressed GLAST (Gc) or PDGF receptorα (Hc). Arrows indicate Olig2+ cells expressing GLAST (Gc) or PDGF receptorα (Hc).
Scale bars in panel A=500 μm, in panels B, C=50 μm, in panel D=100 μm, in insets, Fd,Gd,Hd=20 μm.
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mice, although individual variation was observed (Supplement Fig.
5). In order to enumerate the cells more easily, we next examined
expression of mRNA for FGFR3 and GLAST with an ISH method. In
the E18.5 basal forebrain area (Figs. 8E, F, H, J), the numbers of
FGFR3+ or GLAST+ cells were similar per unit area. For FGFR3,
144±8.48 were seen in the wild/heterozygous mice and 144±10.4
in the Olig2 deﬁcient mice (580 μm×440 μm unit area, n=4 brains
each). For GLAST, 59.2±8.23 were found in wild/heterozygous mice
and 56.5±4.81 in Olig2 deﬁcient mice (290 μm×220 μm unit area,n=5 brains each). Thus, astrocyte development seemed to be
normal in the basal forebrain area without Olig2 function.
However, in the dorsal pallium, especially in the medial part
(Figs. 8E, F), it is surprising that GLAST+ cell density in the cortical
plate and intermediate zone was lower in the Olig2 deﬁcient mice,
compared with the corresponding areas of the wild/heterozygous
mice: 30.7±10.3 in the wild/heterozygous and 15.2±4.74 in the
Olig2 deﬁcient mice (290 μm×220 μm unit area, pb0.05, n=4
brains each) (Figs. 8E–G, I). The distribution of FGFR3+ was also
reduced in number in the Olig2 deﬁcient dorsal pallium compared
Fig. 6. GABAergic and glutamatergic neurons in Olig2 lineage cells. (A–C) GABA+/GFP+ cells in the adult neocortex after the 4-OHT treatment at E12.5. A projection picture of optical
sections taken with a CLSM. (D) A GAD mRNA+/GFP+ cell (arrow) in the adult neocortex with 4-OHT treatment at E12.5. In situ hybridization (blue) followed by GFP
immunoenzymatic staining (brown). (E–H) GAD67 mRNA+/LacZ+ cells in the P7 forebrain following E12.5 4-OHT treatment. X-gal histochemistry (light blue) followed by GAD67 in
situ hybridization (blue). (F) neocortex. (G) hippocampus, (H) thalamic reticular nucleus. (I) A lowmagniﬁcation picture of E17.5 forebrain stained with GAD ISH followed by GFP IHC.
The prethalamic region is magniﬁed in panel J. (J) A higher magniﬁcation picture of GAD67+/GFP+ cells in the prethalamus. (K–M) VGluT1mRNA+/LacZ+ cells in the P7 cortical regions
following E12.5 4-OHT treatment. A few double-positive cells are observed in the piriform cortex (I, J) and the dorsal part of the neocortex (K, L). Scale bars in panels C, H, J, N=20 μm,
in panel D=50 μm, in panels E, I=1 mm, in panel K=500 μm, in panel L=10 μm, in panel M=200 μm.
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13.3±4.10 in the Olig2 deﬁcient mice in 290 μm×220 μm unit area,
pb0.01, n=4 brains each; not shown). These results suggest that
Olig2 plays some roles in the differentiation of astrocytes in theFig. 7. Glutamatergic differentiation of Olig2 lineage cells in the caudal hypothalamus. (A–C)
E10.5 4-OHT treatment. VGluT2 in situ hybridization followed by GFP immunostaining. (D) V
E12.5 4-OHT treatment. X-gal histochemistry followed by VGluT2 in situ hybridization. An arr
(arrow in inset). f, ﬁmbria. mt, mammillothalamic tract. PM, premammillary nuclei. VMH, v
D=20 μm, in panel D=500 μm.dorsal pallium, but not in the basal forebrain. Therefore, as
suggested by others (Marshall et al., 2005; Cai et al., 2007), Olig2
functions in gliogenesis in the neocortex, both oligodendrocytic and
astrocytic.VGluT2 mRNA+/GFP+ cells in the E17.5 ventromedial hypothalamus following E9.5 and
GluT2 mRNA+/LacZ+ cells in the caudal hypothalamus in the adult brain (D) following
ow in panel D indicates localization of a double-labeled cell, which is magniﬁed in inset
entromedial hypothalamic nucleus. Scale bars in panel A=200 μm, in panel C and inset
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Embryonic Olig2+ cells constitute a heterogeneous precursor pool
We examined the differentiative properties of embryonic Olig2+
cells in the forebrain with a tamoxifen-inducible Cre/loxP system. In
the telencephalon, Olig2+ cells at E12.5 (or earlier) differentiated into
neuronal cells, while those in later stages tended to bemacroglial cells.
By contrast, Olig2+ cells in the late fetal diencephalon (this study) or in
the late spinal cord (Masahira et al., 2006) tended to give rise to
oligodendrocytes. These results clearly demonstrated stage- and
region-speciﬁc differentiation of embryonic Olig2+ cells. One of the
most important ﬁndings in this study is that Olig2+ cells in the lateFig. 8. Normal development of GABAergic neurons and altered development of cortical astr
Olig2+/+: (A, C) and Olig2−/− (B, D) mice. Sections were counterstained with nuclear fast red. C
and the densities of GAD expressing cells in the cortex (C, D) were similar inwild type and Ol
G, H) and Olig2−/− (F, I, J) mice. The dorsal pallium (G, I) and basal forebrain (H, J) of panels E an
dorsal pallium (indicated by arrowheads in panel F) was slightly lower in the Olig2 deﬁcient m
Olig2 knockout (E, H) and the wild type (F, J) mice. Density of GLAST+ cells were examined in
(F, I). Asterisks in panels B and F indicate slight enlargement of the third ventricle at the hyp
panel D=100 μm, in panel H=50 μm.fetal telencephalon generate astrocytes and that this is their most
common differentiative fate. Our short-term lineage tracing showed
that Olig2+ cells in the late fetal stage are a mixed population of glial
progenitor cells (see Figs. 5F–H). In addition, Olig2+ cells in the VZ
have characters of radial glial cells in both the dorsal and ventral
telencephalon (Petryniak et al., 2007; Supplement Fig. 1). It is well-
known that cortical radial glia give rise to astrocyte (Schmechel and
Rakic, 1979). We also demonstrated that Olig2 deﬁciency resulted in a
decreased number of astrocyte in the neocortex in the late fetal stage
(see Fig. 8). Our results are consistent with recent reports by Marshall
et al. (2005) and by Cai et al. (2007), demonstrating that Olig2
regulates gliogenesis, both oligodendrocytic and astrocytic, in the
developing telencephalon.ocyte in the absence of Olig2. (A–D) Expression of GAD mRNA in the E18.5 forebrain of
ortical areas are magniﬁed in panels C and D. Overall patterns of GAD expression (A, B)
ig2 deﬁcient mice. (E–J) Expression of GLASTmRNA in the E18.5 forebrain of Olig2+/+: (E,
d F aremagniﬁed in panels G, I and H, J, respectively. Note that GLAST+ cell density in the
ouse (F, I) than in thewild type (E, G), while that in the basal forebrainwas similar in the
the dorsal pallium indicated by arrowheads, and compared between WT (E, G) and KO
othalamic sulcus in the Olig2 deﬁcient mouse. Scale bars in panels A, B, E, F=1 mm, in
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neurons
Most Olig2 lineage neuronal cells are GABAergic neurons in the
telencephalon. GABAergic differentiation of Olig2+ cells was expected
because of their restricted localization in the GE VZ. Homotopic and
homochronic transplantation of GE cells elucidated the temporal and
spatial features of inhibitory neuron production (Wichterle et al.,
2001; Butt et al., 2005b). Detailed analysis of cortical GABAergic
neuron subtypes from Olig2+ cells was reported recently (Miyoshi et
al., 2007). While cortical GABAergic neurons were generated from
ventral Olig2+ progenitor cells by E14.5, olfactory interneurons that
are also GABAergic were generated by Olig2+ cells at late fetal stage
such as E17.5. Therefore, it is probable that some fraction of Olig2+
cells in the late fetal stage are still neurogenic, contributing to
generation of the olfactory bulb interneurons. Recently, Ventura and
Goldman (2007) elucidated that radial glia in the dorsal telencephalon
gives rise to olfactory interneurons in early postnatal stage. Some
GABAergic neurons in the diencephalon are also Olig2 lineage cells.
Many Olig2 lineage recombinant cells are observed in the thalamic
reticular nucleus and ventral thalamus (or prethalamus) where GABA
neurons are the predominant neuronal subtype (see Figs. 6H–J and
8A). Since Olig2 is continuously expressed around the ZLI and the
prethalamic region from the early to the late fetal stage (see Figs. 1F, G,
H), it is highly probable that prethalamic Olig2+ progenitor cells
contribute to GABAergic neurons in this area. It is noteworthy that in
the human fetal brain, a migratory stream from the GE to
diencephalon is observed, and this contributes to GABAergic neurons
in the diencephalon (Letinic and Rakic 2001). However, such a cell
strand is not observed in the rodent or non-human primate brain
(Letinic and Rakic 2001), and therefore, it is less likely that cells in the
telencephalon differentiate to neurons in the rodent diencephalon.
It is possible that glutamatergic differentiation from Olig2+ cells
may be an exceptional or a transient phenotype in the cortex, since the
number of neurons co-expressing VGluT1 and LacZ is limited and also
since the adult brain does not contain recombinant neurons with a
pyramidal proﬁle, typical of excitatory neurons. In contrast, a
considerable number of VGluT2 expressing Olig2 lineage cells appear
in the developing caudal hypothalamus, which persisted in the adult
brain (see Fig. 7). This is the ﬁrst direct evidence for glutamatergic
neuronal differentiation from Olig2 lineage cells. These cells may be
derived from the embryonic hypothalamus (Figs. 1G, K). Thus, our
results clearly demonstrated that the ﬁnal phenotypes of Olig2 lineage
neurons are context-dependent. Both the nature of Olig2+ cells and
inductive signals from the environment may differ among different
regions and stages in the CNS.
Although GABAergic neurons are the major neuronal subtype from
Olig2+ cells, GABAergic neurons can develop at normal density in the
Olig2 knockout cortex (Figs. 8C, D) (Miyoshi et al., 2007). The function
of Olig2 in subtype speciﬁcation or the development of GABAergic
neurons remains unclear.
Migration of Olig2+ precursor cells
Olig2+ cells in the E12.5 telencephalon aremostly localized in the VZ
of the MGE, septum and AEP. In the adult telencephalon, Olig2 lineage
cells marked with GFP or with LacZ upon recombination at E12.5 are
distributed throughout the neocortex. This may reﬂect dorsal tangential
migration of GABAergic neurons (Anderson et al.,1997; Tamamaki et al.,
1997; Tanaka et al., 2003) and, at least in part, of OPCs (Kessaris et al.,
2006; Nakahira et al., 2006). The ventral origins and the subsequent
dorsal dispersal of GABAergic neurons is conserved in the vertebrate
forebrain (Cobos et al., 2001; Katarova et al., 2000; Mueller et al., 2006;
Tuorto et al., 2003). Thus, the GE is an important structure for increasing
the number and heterogeneity of neurons, and probably oligodendro-
cytes as well, in the dorsal pallium. In addition, the olfactory bulbanlagen at E12.5 did not express Olig2 (not shown) whereas recombi-
nantneurons induced atE12.5 resided in the granule andperiglomerular
layers of the adult olfactory bulb (Supplement Fig. 3), suggesting rostral
migration of olfactory neurons from the GE. A considerable number of
recombinant neurons were observed in the adult olfactory bulb after
E17.5 4-OHT treatment. Many of these may also be immigrants from the
GE, as olfactory interneurons are generated in the SVZ, caudal to the
olfactory bulb (Hinds, 1968), throughout life (Lois and Alvarez-Buylla,
1994; Ventura and Goldman, 2007).
OPCs have been shown to originate from the MGE or AEP in the
fetal forebrain, and then migrate towards the neocortex (Kessaris et
al., 2006; Nakahira et al., 2006; Olivier et al., 2001). In addition, recent
evidence suggests that OPCs derived from the basal forebrain at early
stages are replaced with those derived from the dorsal pallium at later
stages during cortical maturation (Kessaris et al., 2006). In our study,
dorsal migration of OPCs is suggested by the occasional appearance of
Olig2 lineage oligodendrocytes in the adult ﬁmbria and GFP+/Olig2+
cells in the fetal cortex following E12.5 4-OHT treatment. The adult
neocortex contains more Olig2 lineage oligodendrocytes when
recombination was induced at E16.5 or later. These results might
indicate that early-generated OPCs migrate dorsally but are replaced
with OPCs generated locally in the neocortex in later stages of
corticogenesis during which dorsal cortical VZ generate Olig2+ cells,
as demonstrated by Kessaris et al. (2006).
Lineage relationship between early and late Olig2+ progenitors
Olig2+ progenitor cells are initially localized in the ventral VZ such
as the MGE and a surrounding area of the ZLI. Olig2, together with
other TFs, regulates oligodendrocytic speciﬁcation in the basal
forebrain (Parras et al., 2007; Petryniak et al. 2007). They subsequently
undergo gradual dispersal throughout the forebrain. Short-term
lineage analysis demonstrated that the majority of Olig2 lineage
cells ceased Olig2 expression within a few days of recombination, and
the great majority of Olig2+ cells were negative for GFP but positive for
PDGFRα or GLAST in the late fetal stage (see Fig. 5), which suggests
that some Olig2+ glial progenitors at a late fetal stage are not direct
cohorts of early ventral Olig2+ cells. Although certain fractions of
ventrally-derived Olig2 lineage cells may reside in the VZ/SVZ of the
dorsal pallium, our observations suggest that such cells also cease
Olig2 expression in the VZ/SVZ (Figs. 5D, E). Therefore, Olig2+ cells in
the VZ/SVZ of the dorsal pallium may acquire Olig2 expression locally
in the pallial VZ/SVZ. In addition, Olig2+ cells seemed to be generated
locally in the VZ of the dorsal telencephalon (Fig. 1 and Supplement
Fig. 1). Indeed, Emx1 lineage cells in the dorsal pallium generate
cortical oligodendrocytes (Gorski et al., 2002). Region- and stage-
dependent differentiative properties of the Olig2+ progenitor cells
may be involved in local generation of Olig2+ progenitors.
In summary, we elucidated the differentiative properties of Olig2+
cells in the fetal forebrain with a stage-speciﬁc recombination
method. Olig2+ cells in the early stages give rise to inhibitory or
excitatory neurons depending on the areas of birth. In late fetal stages,
Olig2+ cells differentiate into macroglial cells, astrocytes or oligoden-
drocytes, again depending on the area of their development. There-
fore, Olig2+ cells form dynamic, heterogeneous progenitor pools
during the development of the forebrain.
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